{"name": "Viral Genetics",
 "permalink": "viral-genetics",
 "crunchbase_url": "http://www.crunchbase.com/company/viral-genetics",
 "homepage_url": "http://www.viralgenetics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1995,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "626-334-5310",
 "description": "Infections Disease Therapeutics",
 "created_at": "Thu Sep 10 11:52:35 UTC 2009",
 "updated_at": "Thu Sep 10 22:59:08 UTC 2009",
 "overview": "\u003Cp\u003EViral Genetics, Inc. engages in the research and development of protein-based therapeutic and diagnostic products with applications in infectious disease, autoimmune conditions, and immunological deficiency. The company discovers, develops, and commercializes a series of proprietary proteins based primarily on Thymus Nuclear Protein (TNP). TNP is a processed extract of mammalian thymus tissue. The company owns 100% of a Chinese subsidiary called Viral Genetics Beijing, Ltd. VGV-1 VGV-1 is a suspension of TNP in alum adjuvant. It is the company\u00e2\u20ac\u2122s lead drug candidate and is a prospective treatment for HIV infection and AIDS. VGV-1 is in the preclinical stage of development in the USA. History Viral Genetics, Inc. was founded in 1995.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       33],
      "assets/images/resized/0005/9346/59346v1-max-150x150.jpg"],
     [[250,
       56],
      "assets/images/resized/0005/9346/59346v1-max-250x250.jpg"],
     [[283,
       64],
      "assets/images/resized/0005/9346/59346v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 241000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.fiercebiotech.com/press-releases/viral-genetics-inc-completes-acquisition-v-clip-pharmaceuticals-inc",
    "source_description": "Viral Genetics, Inc. Completes Acquisition of V-Clip Pharmaceuticals, Inc.",
    "acquired_year": 2008,
    "acquired_month": 11,
    "acquired_day": 17,
    "company":
     {"name": "V-Clip Pharmaceuticals",
      "permalink": "v-clip-pharmaceuticals",
      "image": null}}],
 "offices":
  [{"description": "",
    "address1": "1321 Mountain View Circle",
    "address2": "",
    "zip_code": "91702",
    "city": "Azusa",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}